Jack R Wands Selected Research

Transcription Factors (Transcription Factor)

5/2012	Early growth response-1 transcription factor promotes hepatic fibrosis and steatosis in long-term ethanol-fed Long-Evans rats.
9/2010	Aspartyl-(asparaginyl) beta-hydroxylase, hypoxia-inducible factor-alpha and Notch cross-talk in regulating neuronal motility.
5/2006	Enhanced colon tumor induction in uncoupling protein-2 deficient mice is associated with NF-kappaB activation and oxidative stress.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jack R Wands Research Topics

Disease

47	Neoplasms (Cancer) 04/2022 - 04/2002
33	Hepatocellular Carcinoma (Hepatoma) 04/2022 - 03/2003
24	Insulin Resistance 01/2021 - 02/2005
12	Fatty Liver 02/2014 - 09/2006
11	Inflammation (Inflammations) 01/2021 - 08/2008
10	Alzheimer Disease (Alzheimer's Disease) 01/2009 - 01/2002
9	Cholangiocarcinoma 01/2021 - 05/2003
8	Infections 01/2016 - 02/2004
7	Neoplasm Metastasis (Metastasis) 04/2022 - 11/2004
7	Carcinogenesis 01/2021 - 01/2002
6	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2019 - 08/2007
6	Mitochondrial Diseases (Mitochondrial Disease) 06/2012 - 06/2004
5	Fibrosis (Cirrhosis) 01/2013 - 08/2004
5	Cognitive Dysfunction 01/2010 - 12/2005
5	Carcinoma (Carcinomatosis) 05/2009 - 07/2002
4	Adenocarcinoma 01/2019 - 07/2002
4	Colonic Neoplasms (Colon Cancer) 01/2016 - 09/2004
4	Type 2 Diabetes Mellitus (MODY) 04/2011 - 11/2008
4	Disease Progression 05/2009 - 03/2003
3	Breast Neoplasms (Breast Cancer) 01/2021 - 12/2017
3	Non-alcoholic Fatty Liver Disease 01/2021 - 04/2012
3	Alcoholic Fatty Liver 08/2011 - 01/2009
3	Fetal Alcohol Spectrum Disorders 05/2009 - 09/2007
3	Alcoholism (Alcohol Abuse) 01/2009 - 09/2008
2	Triple Negative Breast Neoplasms 04/2022 - 01/2021
2	Hepatitis C 07/2014 - 02/2006
2	Liver Diseases (Liver Disease) 01/2012 - 08/2011
2	Hypoxia (Hypoxemia) 01/2012 - 09/2010
2	Weight Loss (Weight Reduction) 08/2011 - 01/2010
2	Alcoholic Hepatitis 04/2011 - 07/2009
2	Hepatitis 06/2009 - 11/2005
2	Virus Diseases (Viral Diseases) 06/2009 - 06/2007
2	Obesity 01/2009 - 11/2008
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2007 - 07/2002
2	Neuroblastoma 12/2006 - 07/2002
2	Dementia (Dementias) 09/2006 - 01/2002

Drug/Important Bio-Agent (IBA)

25	Insulin (Novolin)FDA Link 01/2021 - 02/2005
24	Proteins (Proteins, Gene)FDA Link 04/2022 - 01/2002
20	Ethanol (Ethyl Alcohol)IBA 01/2019 - 08/2007
13	Mixed Function Oxygenases (Monooxygenases)IBA 04/2022 - 08/2006
13	CeramidesIBA 02/2014 - 01/2009
12	CytokinesIBA 01/2013 - 02/2006
11	Insulin-Like PeptidesIBA 04/2011 - 01/2002
11	aspartic acid 2-oxoglutarate-dependent dioxygenaseIBA 09/2010 - 07/2002
10	LipidsIBA 01/2021 - 04/2008
9	Aspartic Acid (Aspartate)FDA Link 04/2022 - 01/2012
8	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2010 - 12/2005
7	Biomarkers (Surrogate Marker)IBA 10/2014 - 01/2002
6	VaccinesIBA 04/2022 - 02/2006
6	Messenger RNA (mRNA)IBA 01/2021 - 09/2004
6	Protein Isoforms (Isoforms)IBA 10/2019 - 04/2011
6	CateninsIBA 07/2015 - 04/2011
5	AntigensIBA 04/2022 - 11/2004
5	Monoclonal AntibodiesIBA 01/2019 - 07/2002
5	beta CateninIBA 06/2009 - 10/2004
5	Insulin-Like Growth Factor I (IGF-1)IBA 09/2008 - 02/2005
4	EnzymesIBA 01/2021 - 02/2006
4	Pharmaceutical PreparationsIBA 10/2019 - 11/2004
4	Therapeutic UsesIBA 09/2017 - 09/2006
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016 - 12/2006
4	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2013 - 01/2010
4	Insulin ReceptorIBA 01/2013 - 02/2005
4	DNA (Deoxyribonucleic Acid)IBA 03/2012 - 02/2005
4	Streptozocin (Streptozotocin)FDA Link 01/2009 - 02/2005
4	Amyloid beta-PeptidesIBA 01/2009 - 02/2005
3	Glycogen Synthase KinasesIBA 04/2016 - 03/2006
3	Contrast MediaIBA 03/2016 - 01/2015
3	Glucose (Dextrose)FDA LinkGeneric 04/2014 - 12/2005
3	Triglycerides (Triacylglycerol)IBA 05/2012 - 01/2009
3	Transcription Factors (Transcription Factor)IBA 05/2012 - 05/2006
3	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2009 - 05/2006
3	Uncoupling Protein 2IBA 04/2008 - 09/2004
2	LigandsIBA 04/2022 - 04/2002
2	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 01/2021
2	DioxygenasesIBA 01/2021 - 10/2018
2	Ketoglutaric Acids (Ketoglutaric Acid)IBA 01/2021 - 10/2018
2	Phosphotransferases (Kinase)IBA 12/2017 - 08/2009
2	Hepatitis B e AntigensIBA 01/2016 - 03/2013
2	Small Interfering RNA (siRNA)IBA 01/2016 - 09/2010
2	AntibodiesIBA 10/2015 - 11/2004
2	Peptides (Polypeptides)IBA 03/2015 - 11/2004
2	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 04/2012 - 12/2011
2	Mitogen-Activated Protein KinasesIBA 03/2012 - 05/2003
2	Insulin-Like Growth Factor II (Somatomedin A)IBA 12/2011 - 02/2005
2	AntioxidantsIBA 12/2011 - 05/2009
2	IGF Type 1 Receptor (IGF 1 Receptor)IBA 12/2011 - 09/2008
2	Phosphatidylethanolamine Binding ProteinIBA 01/2011 - 10/2006
2	Peptide Hydrolases (Proteases)FDA Link 11/2010 - 04/2002
2	Insulin Receptor Substrate ProteinsIBA 06/2009 - 11/2005
2	Glycogen Synthase Kinase 3 betaIBA 06/2009 - 09/2008
2	UbiquitinIBA 01/2009 - 03/2006
2	Amyloid (Amyloid Fibrils)IBA 11/2008 - 04/2007
2	Malondialdehyde (Propanedial)IBA 09/2006 - 09/2004
2	Oncogene Proteins (Oncogene Protein)IBA 08/2004 - 01/2002
2	AD7c-NTPIBA 06/2004 - 01/2002
2	SB 203580IBA 06/2003 - 05/2003
2	p38 Mitogen-Activated Protein KinasesIBA 06/2003 - 05/2003

Therapy/Procedure

10	Therapeutics 04/2022 - 11/2004
3	Immunotherapy 04/2022 - 01/2009
3	Drug Therapy (Chemotherapy) 01/2021 - 04/2008